Bioanalytical Systems (BASI) Posts Q2 GAAP Loss of 10c/Share

Bioanalytical Systems (NASDAQ: BASI) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $7.19 million versus the consensus estimate of $7.23 million.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Energizer stock trades 37% below intrinsic value
• Susquehanna Downgrades Canadian National Railway (CNI) to Neutral